{"id":"NCT00641043","sponsor":"Boehringer Ingelheim","briefTitle":"Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone","officialTitle":"A Randomised, Double-blind, Placebo Controlled, Parallel Group 24 Week Study to Assess the Efficacy and Safety of BI 1356 (5 mg) in Combination With 30 mg Pioglitazone (Both Administered Orally Once Daily), Compared to 30 mg Pioglitazone Plus Placebo in Drug Naive or Previously Treated Type 2 Diabetic Patients With Insufficient Glycaemic Control.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-03","primaryCompletion":"2009-06","completion":null,"firstPosted":"2008-03-21","resultsPosted":"2011-06-07","lastUpdate":"2014-02-17"},"enrollment":389,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"placebo + pioglitazone (30 mg)","otherNames":[]},{"type":"DRUG","name":"Linagliptin + pioglitazone (30 mg)","otherNames":[]}],"arms":[{"label":"BI 1356 (5 mg)","type":"EXPERIMENTAL"},{"label":"Placebo matching BI 1356 5 mg","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of the current study is to investigate the efficacy, safety and tolerability of BI 1356 (Linagliptin) (5 mg / once daily) compared to placebo given for 24 weeks as initial combination therapy with pioglitazone 30 mg in patients with type 2 diabetes mellitus with insufficient glycaemic control.","primaryOutcome":{"measure":"HbA1c Change From Baseline to Week 24","timeFrame":"Baseline and week 24","effectByArm":[{"arm":"Placebo + Pioglitazone","deltaMin":-0.56,"sd":0.09},{"arm":"Linagliptin + Pioglitazone","deltaMin":-1.06,"sd":0.06}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":43,"countries":["Austria","Greece","Hungary","Japan","Portugal","Romania","Spain"]},"refs":{"pmids":["22234149"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":130},"commonTop":["Nasopharyngitis","Upper respiratory tract infection"]}}